Cargando…
Vaccinia immune globulin ameliorates eczema vaccinatum in a murine model of atopic dermatitis
Autores principales: | Oyoshi, Michiko K., Ramesh, Narayanaswamy, Geha, Raif S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583535/ https://www.ncbi.nlm.nih.gov/pubmed/22189790 http://dx.doi.org/10.1038/jid.2011.409 |
Ejemplares similares
-
Development of Eczema Vaccinatum in Atopic Mouse Models and Efficacy of MVA Vaccination against Lethal Poxviral Infection
por: Knitlova, Jarmila, et al.
Publicado: (2014) -
Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum
por: Kawakami, Yuko, et al.
Publicado: (2009) -
Eczema herpeticum: A medical emergency in patients with atopic dermatitis
por: Vera-Kellet, Cristián, et al.
Publicado: (2019) -
Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis.
por: Noh, G., et al.
Publicado: (1999) -
PATCH TESTING WITH DERMATOPHAGOIDES AND ITS CORRELATION WITH CHRONIC ECZEMA AND ATOPIC DERMATITIS
por: Kapur, Chetna, et al.
Publicado: (2009)